Table 6 Ischemic arterial events and surrogate measures of atherosclerosis in ACA+ patients versus ACA-patients and controls.
Occurrence of events and atherosclerosis | ACA+ vs. ACA- | ACA+ vs. controls | |||||
|---|---|---|---|---|---|---|---|
ACA+ (n= 34) | ACA- (n= 77) | Controls (n= 105) | Odds ratio** (95% CI) | Pvalue** | Odds ratio* (95% CI) | Pvalue* | |
Any arterial event % (n) | 32 (11) | 11 (9) | 7 (7) | 5.1 (1.57-18.6) | 0.01 | 8.5 (2.6-31.7) | 0.0003 |
IHD % (n) | 18 (6) | 9 (7) | 4 (4) | 2.6 (0.7-10.0) | 0.2 | 4.8 (1.2-20.7) | 0.02 |
ICVD % (n) | 6 (2) | 3 (2) | 3 (3) | 4.0 (0.4-49.0) | 0.2 | 2.0 (0.2-13.9) | 0.6 |
IPVD % (n) | 18 (6) | 4 (3) | 1 (1) | 9.1 (1.6-79.1) | 0.01 | 70.1 (6.5-2524) | <0.0001 |
Plaque % (n) | 65 (22) | 39 (30) | 41 (43) | 3.1(1.2-8.5) | 0.02 | 2.8 (1.1-7.6) | 0.04 |
β-coefficient | β-coefficient | ||||||
IMT mm | 0.69 ± 0.13 | 0.68 ± 0.13 | 0.68 ± 0.13 | 0.03 | 0.7 | 0.01 | 0.6 |
ABI | 1.1(1.03-1.2) | 1.1 (1.17-1.2) | 1.1 (1.07-1.2) | -0.12 | 0.08 | -0.14 | 0.07 |